Proteon’s mission is to improve human and animal health, reducing the reliance on antibiotics, using products developed from our phage-platform technology.
What does it take to turn scientific #Innovation into practical farming solutions?
In the 3rd episode of our video series “Voices of Innovation at Proteon”, our Chief Product & Development Officer, Justyna Andrysiak, shares how we bring #PhageTechnology from concept to market.
Meet our Team: Arkadiusz Wojtasik, PhD
Chief Manufacturing Officer at @Proteonpharma
Arkadiusz leads our manufacturing operations with a clear vision: to deliver high-quality, science-driven solutions that meet the demands of modern, #Sustainable agriculture.
#Leadership
In this episode of “Voices of Innovation at Proteon”, you will hear from our Chief Product & Development Officer, Justyna Andrysiak, who shares her perspective on the potential of #PhageTechnology and the #Innovative approach behind developing #Phage-based solutions.
Our scientists have recently published the article in Frontiers in Microbiology magazine.
The research investigated receptor-binding proteins (RBPs) in #Bacteriophages.
Learn more: https://t.co/eN78kfMarQ
#PhageTherapy#Microbiology#ScientificResearch
We are pleased to confirm that our pioneering #Phage-based zootechnical feed additive, BAFASAL®, has received full regulatory approval from the EU for use in #Poultry. This decision has now been formally published in the Official Journal of the EU.
https://t.co/EVKX76YkIt
We are excited to introduce our new video series, “Voices of #Innovation at Proteon Pharmaceuticals”, launching today across our social media channels.
In the first episode, you will hear from our Founder & Chief Executive Officer, Professor Jaroslaw Dastych.
#Phages
As the challenge of #AMR grows, so does the need for targeted solutions. At Proteon, we are pioneering the use of #phagetechnology that utilises natural mechanisms to selectively neutralise harmful bacteria in farm animals.
Learn more at our website: https://t.co/4MGh4ph7ik
The article, published on the Łódzkie Voivodeship’s portal, offers an in-depth look at our R&D processes and includes insights from Justyna Andrysiak who discusses the team’s efforts to translate cutting-edge science into practical, life-saving solutions.
https://t.co/urxJXt0MJ7
Meet our Team:
Today, we highlight Małgorzata Stańczyk, PhD, our Chief Registration and IP Officer. Małgorzata guides our project teams through the complex regulatory landscape, prepares and submits registration dossiers, and oversees our IP strategy.
#PhageScience#Phages
We are expanding our global reach and are excited to announce that our website is now available in Polish, Portuguese, and Spanish. Now, even more people can explore our products and stay updated with the latest news.
Visit us at https://t.co/4MGh4pgzsM
Which of the following is most critical for protecting our environment through sustainable agriculture?
Vote in the poll below and explore how our work supports a greener tomorrow: https://t.co/AwJ6hKbfID
#WorldEnvironmentDay#Sustainability#Environment
Last week, our Head of Veterinary Services, Rafał Kędzia, attended the XXVIII Poultry Symposium in Zakopane, Poland, where he took part in valuable discussions on #PoultryHealth, nutrition, and production strategies.
#OneHealth#VeterinaryMedicine#AnimalHealth
BAFASAL® is progressing through the final stages of EU regulatory approval. This represents significant progress for both our team at @Proteonpharma and the future of #PhageTechnology in Europe.
Learn more: https://t.co/bgotm1kury
#Bacteriophages
Yesterday, Ewelina Wójcik, PhD, joined the panel discission during Advancing Solutions to Antimicrobial Resistance (#AS2AMR) Conference in Brussels. She delivered a talk focusing on the regulatory challenges behind phage-based solutions.
#OneHealth#InnovationInBiotech#AMR
Meet our Team: Justyna Andrysiak
Chief Product & Technology Officer at @Proteonpharma
From enhancing animal welfare to restoring microbial balance and minimizing farming’s environmental impact, her work turns scientific potential into practical solutions.
#Leadership#Phages
Dr. Ewelina Wójcik, Chief Scientific Officer of @Proteonpharma, will speak at the #AS2AMR Conference in Brussels. On May 26, during Day 1 of the conference, Ewelina will join the panel discussion focusing on current regulations and legislations.
https://t.co/PZ55LB4UNk
The recently published article in MDPI magazine, “Bacteriophage Therapy in Freshwater and Saltwater Aquaculture Species” reinforces the increasing potential of phage therapy as a solution in #Aquaculture. At Proteon, we see growing interest in precision phage applications.
Meet our Team: Prof. Jarosław Dastych
Founder & CEO of @Proteonpharma
With a passion for scientific innovation and a clear mission, Prof. Dastych has led Proteon from idea to impact, developing bacteriophage-based solutions that protect #AnimalHealth.
#Leadership#PhageScience
As spring unfolds and water temperatures rise, the risk of bacterial infections in aquaculture grows, his week, we’re revisiting on of our articles published in Viruses (MDPI), highlighting the role of #Bacteriophages in protecting fish and shrimp health.
https://t.co/rFtkYpcdjj